Three strikes and you’re out? Not for Supernus and its Parkinson’s disease infusion pump. | The device is meant to allow ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The company could announce the separation of the business, which consists of biosciences and diagnostic solutions, at the ...

Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) climbed 5.5% Tuesday as the U.S. Food and Drug Administration approved ...

HE is the highest-paid football player in the world, with a net worth of over £229million and a portfolio of luxury properties across six countries. It’s a level of wealth that Cristiano ...

Stifel analysts maintained their Hold rating on Supernus Pharmaceuticals (NASDAQ:SUPN) shares, with a steady price target of $38.00. Trading near its 52-week high with a strong 30% gain over the past ...

The lack of awareness about rare diseases like prurigo nodularis and available treatment options is anticipated to impede market growth.